Retraction
RUNX3-regulated circRNA METTL3 inhibits colorectal cancer proliferation and metastasis via miR-107/PER3 axis
Paper Information
Record ID:
51935
Author(s):
Journal:
Publication Date:
June 16, 2022
Retraction Date:
February 07, 2024
(1.8 year years ago)
Subjects:
Institutions:
- Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, 410008, Changsha, Hunan, P.R. China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, 410008, Changsha, Hunan, P.R. China
- The Institute of Medical Sciences, Xiangya Hospital, Central South University, 410008, Changsha, Hunan, P.R. China
- Department of Health Management Center, Xiangya Hospital, Central South University, 410008, Changsha, Hunan Province, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1038/s41419-024-06497-wAdditional Notes:
see also: https://pubpeer.com/publications/8ACC44B5ECD97423A1BAC0C997783C
Citations (31)
31
Total Citations14
Post-Retraction(45.2%)
17
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
3
Within 30 days
9
Within 1 year
0
After 2+ years
489
Days since retraction (latest)
Role of the period family in mediating the interplay between circadian disruption and cancer (Review)
Pengfei Gu, Wenjian Xu, Xiaorui Fan et al. (8 authors)
Oncology Letters
Open Access
Published: Jun 2025
489 days after retraction
The regulation of LRPs by miRNAs in cancer: influencing cancer characteristics and responses to treatment
Lianyue Qu, Fan Wang, Yuxiang Wang et al. (4 authors)
Cancer Cell International
Open Access
Published: May 2025
465 days after retraction
The emerging functions and clinical implications of circRNAs in acute myeloid leukaemia
Shuiqing Liu, Xingyu Wan, Yang Gou et al. (9 authors)
Cancer Cell International
Open Access
Published: Apr 2025
447 days after retraction
Prognostic and predictive molecular biomarkers in colorectal cancer
Jianzhi Zhang, Hao Zhu, Wentao Liu et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Apr 2025
434 days after retraction
Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axis
Jingjing Zhang, Tiaotiao Chen, Wencheng Wu et al. (7 authors)
Cancer Cell International
Open Access
Published: Apr 2025
433 days after retraction
Circular RNAs: Therapeutic Uses in Colorectal Cancer
Muthusamy Thangavel, Chalini Vijayakumar, Deepalakkshmi Balakrishnan
International Journal of experimental research and review
Open Access
Published: Nov 2024
1 citation
1 citation
297 days after retraction
Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)
Xiaoyu Zhang, Lei Shi, Mengzhen Xing et al. (7 authors)
International Journal of Molecular Medicine
Open Access
Published: Nov 2024
2 citations
2 citations
274 days after retraction
Challenges and advances of immune checkpoint therapy
Lingyu Li, Yingli Sun
Clinical and Translational Discovery
Open Access
Published: Nov 2024
271 days after retraction
CircMETTL3-156aa reshapes the glycolytic metabolism of macrophages to promote M1 polarization and induce cytokine storms in sHLH
Longlong Xie, Xiangying Deng, Xiaoli Li et al. (12 authors)
Cell Death Discovery
Open Access
Published: Oct 2024
245 days after retraction
Review of METTL3 in colorectal cancer: From mechanisms to the therapeutic potential
Lexuan Zhang, Zhenwei Mao, Kai Yin et al. (4 authors)
International Journal of Biological Macromolecules
Published: Jul 2024
2 citations
2 citations
170 days after retraction
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)
Meng-jun Qiu, Youxiang Chen, Chunyan Zeng
International Journal of Oncology
Open Access
Published: Mar 2024
2 citations
2 citations
37 days after retraction
Potential therapeutic strategy for cancer: Multi-dimensional cross-talk between circRNAs and parental genes
Xiaoyu Sun, Xinyi Zhao, Yan Xu et al. (7 authors)
Cancer Letters
Published: Mar 2024
9 citations
9 citations
28 days after retraction
RUNX transcription factors: biological functions and implications in cancer
Xinyi Chen, Lu Wang, Mu Yang et al. (7 authors)
Clinical and Experimental Medicine
Open Access
Published: Mar 2024
5 citations
5 citations
24 days after retraction
Roles of circRNAs in the progression of colorectal cancer: novel strategies for detection and therapy
Jun J. Mao, Ying Lu
Cancer Gene Therapy
Published: Feb 2024
6 citations
6 citations
2 days after retraction
Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis
Liu Ming-sheng, Chenxiang Xu, Hua Yang et al. (11 authors)
Journal of Cancer
Open Access
Published: Jan 2024
3 citations
3 citations
37 days before retraction
Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review)
Chi-Yun Shao, Yanjie Han, Yuying Huang et al. (10 authors)
International Journal of Oncology
Open Access
Published: Dec 2023
11 citations
11 citations
50 days before retraction
New insights into the regulation of METTL3 and its role in tumors
Jin Qiu, Huinan Qu, Chengshi Quan
Cell Communication and Signaling
Open Access
Published: Nov 2023
24 citations
24 citations
76 days before retraction
Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers
Tian-Hao Guo, Shuoqi Zhao, Wenjian Zhu et al. (5 authors)
Heliyon
Open Access
Published: Oct 2023
2 citations
2 citations
110 days before retraction
The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy
Haodong Zhu, Jiawei Chen, Zeqin Wen et al. (7 authors)
Life Sciences
Open Access
Published: Oct 2023
7 citations
7 citations
126 days before retraction
Non-coding RNAs’ function in cancer development, diagnosis and therapy
Xinyi Zhang, Xiaoqing Xu, Jiajia Song et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2023
17 citations
17 citations
136 days before retraction
Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis
Chenghao Wu, Shaobo Yu, Yanzhong Wang et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Aug 2023
4 citations
4 citations
160 days before retraction
Circ_0067934: a circular RNA with roles in human cancer
Li‐Qing Yu, Jiacheng Zheng, Jiali Yu et al. (5 authors)
Human Cell
Open Access
Published: Aug 2023
4 citations
4 citations
174 days before retraction
MiR-485-3p/MiR-543/MiR-337-3p is Required for the Oncogenic Potential of the Hsa_circ_0007385-MEMO1 Axis in Colorectal Cancer
Jun‐Feng Yin, Guanglan Liu, Xinguo Zhu
Biochemical Genetics
Published: Aug 2023
2 citations
2 citations
181 days before retraction
RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis
Selvaraj Vimalraj, Saravanan Sekaran
Cancers
Open Access
Published: Jun 2023
8 citations
8 citations
233 days before retraction
CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
Yuying Zhang, Jingyan Luo, Weikang Yang et al. (4 authors)
Cell Death and Disease
Open Access
Published: Jun 2023
79 citations
79 citations
243 days before retraction
METTL9 derived circular RNA circ-METTL9 sponges miR-551b-5p to accelerate colorectal cancer progression by upregulating CDK6
Ming Li, Zheng Zhi, Xuan Jiang et al. (14 authors)
Carcinogenesis
Published: May 2023
8 citations
8 citations
274 days before retraction
CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling
Dejun Wu, Yuqin Li, Anjun Xu et al. (5 authors)
Cancers
Open Access
Published: Mar 2023
14 citations
14 citations
314 days before retraction
The potential role and mechanism of circRNAs in foam cell formation
Wujun Chen, Yihui Liu, Ling Li et al. (8 authors)
Non-coding RNA Research
Open Access
Published: Mar 2023
10 citations
10 citations
323 days before retraction
Role of RUNX2 in breast cancer development and drug resistance (Review)
Wentao Si, Kan Chen, Leisheng Zhang et al. (4 authors)
Oncology Letters
Open Access
Published: Mar 2023
5 citations
5 citations
329 days before retraction
FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression
Mujie Ye, Chunhua Hu, Tiaotiao Chen et al. (14 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2023
21 citations
21 citations
402 days before retraction
Downregulation of FABP5 suppresses mTOR -mediated autophagy via an increase in FASN to promote colorectal cancer progression
Mujie Ye, Tiaotiao Chen, Chunhua Hu et al. (12 authors)
Research Square (Research Square)
Open Access
Published: Sep 2022
509 days before retraction
Quick Stats
Total Citations:
31
Years Since Retraction:
1.8 year
Open Access:
Yes
Last Checked:
Jul 24, 2025